Location History:
- King of Prussia, PA (US) (2018)
- Philadelphia, PA (US) (2018)
- Deerfield, IL (US) (2024)
Company Filing History:
Years Active: 2018-2024
Title: The Innovative Mind of Matthew Callahan
Introduction
Matthew Callahan, an accomplished inventor based in King of Prussia, Pennsylvania, has made significant contributions to the fields of material preparation and inhalable pharmaceuticals. With three patents to his name, Callahan's innovations reflect his expertise and commitment to advancing technology in these areas.
Latest Patents
Callahan's latest patents include a "Method and apparatus for using encoded information for material preparation and analysis equipment." This innovation provides a disclosure for utilizing indicia to handle information effectively in material preparation and analysis. Additionally, he holds a patent for "Inhalable pharmaceutical compositions," which describes methods for creating inhalable composite particles containing a pharmaceutically active agent. This method involves providing composite particles with a specific median particle size and milling these particles to achieve an optimal mass median aerodynamic diameter for inhalation.
Career Highlights
Throughout his career, Callahan has worked with notable companies, including Iceutica Inc. and Iceutica Pty Ltd. His time in these organizations has allowed him to further develop his expertise in creating groundbreaking technologies that enhance pharmaceutical applications.
Collaborations
In his journey as an inventor, Callahan has collaborated with talented professionals such as H William Bosch and Marck Norret. These collaborations have contributed to the advancement of his projects and the successful development of his patents.
Conclusion
Matthew Callahan is an inspiring figure in the realm of innovation, demonstrating that dedication to research and development can lead to significant advancements in technology. His patents not only showcase his technical skills but also his ability to address pressing needs in material science and pharmaceuticals, positioning him as a key innovator in these fields.